Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614289 · ClinicalTrials.gov registry record · Phase 1
Novel Topical Treatment of Hand Dermatitis (Eczema)
A Phase 1 study, sponsored by Biomedical Development Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00614289 is a Phase 1 study that has completed, run by Biomedical Development Corporation. The registered enrollment target is 30 participants.
The verdict
NCT00614289, a Phase 1 study, has completed, sponsored by Biomedical Development Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is designed as a prospective, randomized, double-blind right/left comparison of Epikeia coatings to improve hand dermatitis.
Interventions
- DEVICE Epikeia Coatings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614289
The ClinicalTrials.gov registry entry for NCT00614289 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomedical Development Corporation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epikeia Coatings is the first listed.
NCT00614289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614289 about?
NCT00614289 is a clinical study titled "Novel Topical Treatment of Hand Dermatitis (Eczema)". This study is designed as a prospective, randomized, double-blind right/left comparison of Epikeia coatings to improve hand dermatitis.
What is the current status of trial NCT00614289?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2006-08. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00614289?
The interventions under investigation include: Epikeia Coatings (DEVICE).
Who is sponsoring clinical trial NCT00614289?
This trial is sponsored by Biomedical Development Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.